Home
News
Create
Screeners
Insights
Lactose
98.
00
+1.56
(+1.62%)
Market Cap
₹123.36 Cr
PE Ratio
25.11
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.62%
1M
-2.73%
6M
+0.39%
1Y
-21.03%
5Y
+341.44%
View Company Insights
Latest news about Lactose
Lactose India Adopts New Business Line in Specialized Pharmaceutical Excipients with ₹15 Crore Investment
Jan 30, 2026
Lactose (India) Limited has adopted a new business line in specialized pharmaceutical excipients with a ₹15 crore investment in plant & machinery and infrastructure. The company launched four value-added lactose products including Spray Dried Lactose, Anhydrous Lactose, Homoeopathic Grade Lactose, and Inhalation Grade Lactose. The expansion aims to improve margins, reduce import dependence, and strengthen customer relationships while supporting domestic pharmaceutical manufacturing initiatives.
SST Private Family Trust Completes SEBI Disclosure for Lactose India Stake Transfer
Dec 10, 2025
Lactose India Limited's Credit Rating Reaffirmed at CRISIL BBB-/Stable
Oct 24, 2025
Lactose (India) Limited Secures BSE Approval for Vitanosh Ingredients Merger
Aug 23, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation